Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
disease | 1.000 | None | 0.974 | 0 | 0 | 2000 | 2019 | |||||||||
|
solute carrier family 19 member 2 | 0.636 | 0.692 | 4.3E-04 |
|
disease | 1.000 | None | 1.000 | 0 | 0 | 1997 | 2019 | ||||||||
|
gap junction protein beta 6 | 0.528 | 0.808 | 1.7E-07 |
|
disease | 1.000 | definitive | 1.000 | 0 | 0 | 1998 | 2019 | ||||||||
|
AFG3 like matrix AAA peptidase subunit 2 | 0.588 | 0.462 | 5.3E-09 |
|
disease | 1.000 | None | 0.958 | 0 | 0 | 2009 | 2019 | ||||||||
|
solute carrier family 7 member 9 | 0.666 | 0.692 | 9.1E-10 |
|
disease | 1.000 | definitive | 1.000 | 0 | 0 | 1999 | 2018 | ||||||||
|
CHM Rab escort protein | 0.592 | 0.654 | 1.00 |
|
disease | 1.000 | None | 0.965 | 0 | 0 | 1987 | 2020 | ||||||||
|
lysosomal trafficking regulator | 0.621 | 0.692 | 1.5E-02 |
|
disease | 1.000 | None | 0.982 | 0 | 0 | 1968 | 2019 | ||||||||
|
EF-hand domain containing 1 | 0.659 | 0.231 | 1.9E-17 |
|
disease | 1.000 | disputed | 0.979 | 0 | 0 | 1993 | 2019 | ||||||||
|
C1q and TNF related 5 | 0.663 | 0.346 | 0.84 |
|
disease | 1.000 | None | 1.000 | 0 | 0 | 2003 | 2019 | ||||||||
|
tripeptidyl peptidase 1 | 0.551 | 0.808 | 6.3E-07 |
|
disease | 1.000 | None | 1.000 | 0 | 0 | 1997 | 2019 | ||||||||
|
CLN3 lysosomal/endosomal transmembrane protein, battenin | 0.572 | 0.692 | 1.3E-07 |
|
disease | 1.000 | None | 0.994 | 0 | 0 | 1990 | 2019 | ||||||||
|
collagen type II alpha 1 chain | 0.444 | 0.846 | 1.00 |
|
disease | 1.000 | None | 0.981 | 0 | 0 | 1989 | 2020 | ||||||||
|
collagen type III alpha 1 chain | 0.477 | 0.808 | 1.00 |
|
disease | 1.000 | definitive | 1.000 | 0 | 0 | 1980 | 2019 | ||||||||
|
collagen type VI alpha 1 chain | 0.587 | 0.731 | 1.00 |
|
disease | 1.000 | None | 1.000 | 0 | 0 | 1993 | 2019 | ||||||||
|
collagen type VI alpha 3 chain | 0.563 | 0.769 | 1.8E-20 |
|
disease | 1.000 | strong | 1.000 | 0 | 0 | 2002 | 2018 | ||||||||
|
collagen type VII alpha 1 chain | 0.545 | 0.808 | 2.4E-40 |
|
disease | 1.000 | strong | 0.983 | 0 | 0 | 1993 | 2020 | ||||||||
|
EvC ciliary complex subunit 2 | 0.585 | 0.692 | 1.0E-34 |
|
disease | 1.000 | definitive | 1.000 | 0 | 0 | 2002 | 2018 | ||||||||
|
dihydrolipoamide branched chain transacylase E2 | 0.638 | 0.462 | 1.0E-05 |
|
disease | 1.000 | definitive | 1.000 | 0 | 0 | 1991 | 2020 | ||||||||
|
aspartylglucosaminidase | 0.570 | 0.808 | 4.3E-06 |
|
phenotype | 1.000 | None | 0.960 | 0 | 0 | 1990 | 2019 | ||||||||
|
solute carrier family 26 member 3 | 0.554 | 0.692 | 1.4E-13 |
|
disease | 1.000 | strong | 0.964 | 0 | 0 | 1996 | 2019 | ||||||||
|
endothelin receptor type B | 0.470 | 0.846 | 9.2E-03 |
|
disease | 1.000 | moderate | 1.000 | 0 | 0 | 1994 | 2018 | ||||||||
|
ubiquitin protein ligase E3 component n-recognin 1 | 0.612 | 0.731 | 5.5E-03 |
|
disease | 1.000 | strong | 1.000 | 0 | 0 | 2002 | 2018 | ||||||||
|
ERCC excision repair 2, TFIIH core complex helicase subunit | 0.420 | 0.846 | 7.1E-20 |
|
disease | 1.000 | definitive | 0.935 | 0 | 0 | 1977 | 2017 | ||||||||
|
ERCC excision repair 3, TFIIH core complex helicase subunit | 0.504 | 0.846 | 3.4E-11 |
|
disease | 1.000 | definitive | 1.000 | 0 | 0 | 1990 | 2019 | ||||||||
|
ERCC excision repair 4, endonuclease catalytic subunit | 0.468 | 0.846 | 1.4E-12 |
|
disease | 1.000 | definitive | 1.000 | 0 | 0 | 1988 | 2019 |